Rationale and Design of the Pragmatic Randomized Trial of Icosapent Ethyl for High Cardiovascular Risk Adults (MITIGATE)
Author(s): Ambrosy AP; Skarbinski J; Go AS; et al.
Am Heart J. 2021 Jan 28.
PubMed abstractAssociation of Mortality and Years of Potential Life Lost With Active Tuberculosis in the United States
Author(s): Lee-Rodriguez C; Wada PY; Hung YY; Skarbinski J
JAMA Netw Open. 2020 Sep 01;3(9):e2014481. Epub 2020-09-01.
PubMed abstractObesity and Mortality Among Patients Diagnosed With COVID-19: Results From an Integrated Health Care Organization
Author(s): Tartof SY; Skarbinski J; Murali SB; et al.
Ann Intern Med. 2020 Aug 12.
PubMed abstractBurden of Active Tuberculosis in an Integrated Health Care System, 1997-2016: Incidence, Mortality, and Excess Health Care Utilization
Author(s): Wada PY; Lee-Rodriguez C; Hung YY; Skarbinski J
Open Forum Infect Dis. 2020 Jan;7(1):ofaa015. Epub 2020-01-12.
PubMed abstractComparison of msp genotyping and a 24 SNP molecular assay for differentiating Plasmodium falciparum recrudescence from reinfection
Author(s): Fulakeza J; McNitt S; Vareta J; Saidi A; Mvula G; Taylor T; Mathanga DP; Small DS; Skarbinski J; Gutman JR; Seydel K
Malar J. 2019 Mar 18;18(1):84. Epub 2019-03-18.
PubMed abstractEpidemiology, detection, and management of tuberculosis among end-stage renal disease patients
Author(s): Okada RC; Barry PM; Skarbinski J; Chitnis AS
Infect Control Hosp Epidemiol. 2018 11;39(11):1367-1374. Epub 2018-09-20.
PubMed abstract